Načítá se...
Bempedoic acid for the treatment of dyslipidemia
Cardiovascular disease (CVD) is the leading cause of death worldwide and one key factor associated with the increased CVD risk is dyslipidemia. Statin therapy remains the first-line treatment to manage dyslipidemia, yet many patients do not achieve optimal low-density lipoprotein-cholesterol (LDL-C)...
Uloženo v:
| Vydáno v: | Drugs Context |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioExcel Publishing Ltd
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7449648/ https://ncbi.nlm.nih.gov/pubmed/32922503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.2020-6-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|